Safe medications thanks to new test procedures

High-Tech Gründerfonds is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that has been established to support pharmaceutical research. The technology is based on special antibodies and allows the early detection of possible side effects during the drug development process. Thereby, the need for animal testing will be reduced while the drug becomes safer and the process more cost-efficient. SIGNATOPE has already secured a number of renowned companies as clients of the new technique.

(Stuttgart/Tübingen/Bonn) - High-Tech Gründerfonds is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that has been established to support pharmaceutical research. The technology is based on special antibodies and allows the early detection of possible side effects during the drug development process. Thereby, the need for animal testing will be reduced while the drug becomes safer and the process more cost-efficient. SIGNATOPE has already secured a number of renowned companies as clients of the new technique.

Before new drugs get approval they are subjected to comprehensive tests in cell culture and animal models to assess their efficacy and toxicity. The biomarker assays developed by SIGNATOPE are able to detect organ damage and drug side effects. As biomarkers might differ between humans and animal models, to date a multitude of tests have been applied for this analysis. During phase I of the GO-Bio program, which is being funded by the German Federal Ministry of Education and Research, the team at the NMI Natural and Medical Sciences Institute at the University of Tübingen developed a novel technique, which quantifies relevant biomarkers not only in humans but also across a wide variety of species. "Our technique delivers quantitatively comparable data, regardless of the selected test model. We are able to detect even the tiniest amount of biomarkers in urine and blood samples. This helps to cut down significantly on time and costs with respect to drug development," explains Oliver Pötz, CEO at SIGNATOPE.

As a major German seed stage investor, HTGF sees huge potential in the new approach devised by the Reutlingen researchers. "The team really impressed us with this pioneering technology. In comparison to traditional histopathological techniques involving tissue sections, non-invasive biomarker assays are becoming increasingly relevant in the development of new drugs," explains Dr. Lena Krzyzak, Investment Manager at HTGF.

SIGNATOPE was founded by scientists Hannes Planatscher, Thomas Joos, Octavian Schatz and Oliver Pötz, together with the NMI. "As a business-minded incubator, the NMI is the nucleus behind many successful start-ups," explains Dr. Klaus Eichenberg, Managing Director of BioRegio STERN Management GmbH (http://www.bioregio-stern.de/en). "It is a good example of how to fuse innovative research with successful business in the region."


Firmenkontakt
BioRegio STERN Management GmbH
Klaus Eichenberg
Friedrichstrasse 10
70174 Stuttgart
+49 (0)711-870354-0
info@bioregio-stern.de
http://www.bioregio-stern.de/en


Pressekontakt
Zeeb Kommunikation GmbH
Anja Pätzold
Hohenheimer Straße 58a
70174 Stuttgart
+49 (0)711-6070719
info@zeeb.info
http://www.zeeb.info


Contact Details

Company Name: Zeeb Kommunikation GmbH
Issued By: Anja Pätzold
Phone: +49 (0)711-6070719
Address: Hohenheimer Straße 58a
City: Stuttgart
State: Baden-Württemberg
Zip: 70174
Country: Germany
Website: Visit the website

Keywords : Signatope, NMI, medications, biomarker, HTGF, BioRegio STERN,

by Anja Pätzold (few months ago!)

Latest Press Releases

Global Food Additives Market - Global Industry Insights ,Industry Forecast till 2025

Automotive Friction Brake System Market Trends and Global Forecast to 2022

Wearing a Justin Bieber Necklace is a Truth Now for Customers of Bieber-Clothing.Com

Security Paper Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, ..

Software Defined Everything Market Analysis, Segments, Key Players, Drivers, Trends by Foreca..

Robert Miller Recognizes Future Electronics Team for Global Agreement with CAEN RFID

Electronic Medical Records Market Size To Reach Close To US$ 40 Billion upto 2024

Could Frequent Self-Pleasuring Improve Overall Health?

CC Wholesale Clothing is the best store for close out clothing online

Smyrna Locksmiths

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.